Coronavirus October 3, 2020 6:17 pm What to Know About Remdesivir President Donald Trump’s doctors have said that he is now on a five-day course of remdesivir to treat his COVID-19. The anti-viral drug made by Gilead Sciences has been the subject of several clinical trials in Boston. US & World Videos 2:09 President of MIT calls for shutting down pro-Palestinian encampments 1:00 Three dead in apparent murder-suicide in Lowell 3:05 100 protesters detained at Northeastern University 2:39 Community mourns police sergeant killed on duty 2:50 Community mourns Billerica police sergeant killed on duty